Simvastatin as add-on therapy to interferon B-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial

: Sorensen PS, Lycke J, Erälinna JP, Edland A, Wu X, Frederiksen JL, Oturai A, Malmeström C, Stenager E, Sellebjerg F, Sondergaard HB

: 2011

: Lancet Neurology

: 8

: 10

: 8

: 691

: 701

: 11

: 1474-4422

DOI: https://doi.org/10.1016/S1474-4422(11)70144-2